FDA Orange Book · active-ingredient family
Sodium nitrite; sodium thiosulfate
Sodium nitrite; sodium thiosulfate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:NITHIODOTE · NDA 201444
1
Brand (NDA)
0
Generics (ANDA)
8
Listed patents
0
Exclusivity periods
Brand (NDA) products · solution, solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| NITHIODOTERLD | HOPE PHARMS | NDA 201444 | — | Jan 14, 2011 |
Listed patents (8)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11753301 | Feb 10, 2030 | in 3 yr 8 mo | SubstanceProductU-3681 |
| 9687506 | Feb 10, 2030 | in 3 yr 8 mo | ProductU-3394 |
| 12304813 | Feb 10, 2030 | in 3 yr 8 mo | Product |
| 9345724 | Jul 07, 2030 | in 4 yr 1 mo | SubstanceProductU-2015 |
| 10479686 | Jul 07, 2030 | in 4 yr 1 mo | ProductU-3390 |
| 9585912 | Jul 07, 2030 | in 4 yr 1 mo | SubstanceProduct |
| 8496973 | Mar 29, 2031 | in 4 yr 10 mo | SubstanceProductU-1419 |
| 8568793 | Dec 24, 2031 | in 5 yr 7 mo | SubstanceProduct |
Sodium nitrite; sodium thiosulfate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

